Search

everythinglearnresearchcommunity

for

Search:↓

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Finasteride may improve prostate cancer treatment outcomes.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Androgenetic alopecia in women needs more research and better management strategies.

Flutamide reduces hair growth better but has more side effects.

Finasteride works better than Serenoa repens for male hair loss.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.